Rankings
▼
Calendar
AMPH FY 2011 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$832M
FY 2011 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$118M
Gross Profit
$28M
23.7% margin
Operating Income
-$34M
-28.3% margin
Net Income
$8M
6.5% margin
EPS (Diluted)
$0.97
Cash Flow
Operating Cash Flow
$19M
Free Cash Flow
$8M
Stock-Based Comp.
$8M
← FY 2012
All Quarters
